By Allissa Wickham ( June 13, 2014, 5:29 PM EDT) -- The U.S. government on Thursday weighed in on Celgene Corp.'s bid to nix a whistleblower's False Claims Act suit in California federal court over alleged off-label drug promotions and kickbacks to doctors, arguing the drug company prematurely moved for dismissal and relied on faulty theories about what constitutes a false claim....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.